Bupivacaine liposome injectable suspension compared with bupivacaine HCl for the reduction of opioid burden in the postsurgical setting

Current Medical Research and Opinion

Volumn 28, Issue 10, 2012, Pages 1609-1615

  Dasta, Joseph ^a   Ramamoorthy, Sonia ^b   Patou, Gary ^c   Sinatra, Raymond ^d  

^a University of Texas College of Pharmacy   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Pacira Pharmaceuticals Inc   (United States)

^d YALE NEW HAVEN HOSPITAL   (United States)

Author keywords

Analgesic; Infiltration; Liposome bupivacaine; Opioid sparing; Opioid related adverse event; Postsurgical analgesia; Postsurgical pain

Indexed keywords

BUPIVACAINE; OPIATE;

ADULT; ANEMIA; AREA UNDER THE CURVE; ARTHRALGIA; ARTICLE; BACKACHE; BREAST AUGMENTATION; BUNIONECTOMY; CHILL; CONSTIPATION; CONTROLLED CLINICAL TRIAL (TOPIC); CONTROLLED STUDY; DIZZINESS; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; DRUG SAFETY; FEMALE; FEVER; HEADACHE; HEMORRHOIDECTOMY; HERNIOPLASTY; HUMAN; HYPERTENSION; HYPESTHESIA; HYPOKALEMIA; HYPOTENSION; INCIDENCE; INGUINAL HERNIA; INSOMNIA; MAJOR CLINICAL STUDY; MALE; MUSCLE SPASM; NAUSEA; NUMERIC RATING SCALE; OUTCOME ASSESSMENT; PAIN; PAIN ASSESSMENT; PERIPHERAL EDEMA; POSTOPERATIVE ANALGESIA; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PAIN; PRURITUS; SINGLE DRUG DOSE; SOMNOLENCE; SUSPENSION; TACHYCARDIA; TOTAL KNEE REPLACEMENT; VOMITING;

ADULT; AGED; ANALGESICS, OPIOID; ANESTHETICS, LOCAL; BUPIVACAINE; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LIPOSOMES; MALE; MIDDLE AGED; PAIN MEASUREMENT; PAIN, POSTOPERATIVE;

EID: 84867848245     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007995.2012.721760     Document Type: Article

References (33)

1. Apfelbaum JL, Chen C, Mehta SS, et al. Postoperative pain experience: results from a national survey suggest postoperative pain continues to be undermanaged. Anesth Analg 2003;97:534-40. (Pubitemid 36899761)
2. Sommer M, de Rijke JM, Van Kleef M, et al. The prevalence of postoperative pain in a sample of 1490 surgical inpatients. Eur J Anaesthesiol 2008;25:267-74. (Pubitemid 351365300)
3. Adamson RT, Lew I, Beyzarov E, et al. Clinical and economic implications of postsurgical use of opioid therapy. Hosp Pharm 2011;46(6 Suppl 1):S4-11.
4. Pavlin DJ, Chen C, Penaloza DA, et al. Pain as a factor complicating recovery and discharge after ambulatory surgery. Anesth Analg 2002;95:627-34. (Pubitemid 35006855)
5. Chung F, Ritchie E, Su J. Postoperative pain in ambulatory surgery. Anesth Analg 1997;85:808-16. (Pubitemid 27418884)
6. Practice guidelines for acute pain management in the perioperative setting: an updated report by the American Society of Anesthesiologists Task Force on Acute Pain Management. Anesthesiology 2004;100:1573-81
7. White PF. Multimodal pain management-the future is now! Curr Opin Investig Drugs 2007;8:517-18 (Pubitemid 47016318)
8. Shang AB, Gan TJ. Optimising postoperative pain management in the ambulatory patient. Drugs 2003;63:855-67. (Pubitemid 36543083)
9. Wheeler M, Oderda GM, Ashburn MA, et al. Adverse events associated with postoperative opioid analgesia: a systematic review. J Pain 2002;3:159-80. (Pubitemid 34663605)
10. Oderda GM, Said Q, Evans RS, et al. Opioid-related adverse drug events in surgical hospitalizations: impact on costs and length of stay. Ann Pharmacother 2007;41:400-6.
11. Oderda GM, Gan TJ, Robinson S, et al. Opioid-related adverse events increase length of stay and drive up total cost of care in a national database of postsurgical patients [abstract]. Presented at: Annual Midyear Clinical Meeting of the American Society of Health-System Pharmacists, 4-8 December 2011, New Orleans, LA, USA.
12. Jirasiritham S, Tantivitayatan K, Jirasiritham S. Perianal blockage with 0.5% bupivacaine for postoperative pain relief in hemorrhoidectomy. J Med Assoc Thai 2004;87:660-4. (Pubitemid 39163105)
13. Chester JF, Stanford BJ, Gazet JC. Analgesic benefit of locally injected bupivacaine after hemorrhoidectomy. Dis Colon Rectum 1990;33:487-9. (Pubitemid 20187508)
14. Moiniche S, Mikkelsen S, Wetterslev J, et al. A qualitative systematic review of incisional local anaesthesia for postoperative pain relief after abdominal operations. Br J Anaesth 1998;81:377-83. (Pubitemid 28416617)
15. Haas E, Onel E, Miller H, et al. A double-blind, randomized, active-controlled study for post-hemorrhoidectomy pain management with liposome bupivacaine, a novel local analgesic formulation. Am Surg 2012;78:574-81.
16. Bramlett K, Onel E, Viscusi ER, et al. A randomized, double-blind, doseranging study comparing wound infiltration of DepoFoam bupivacaine, an extended-release liposomal bupivacaine, to bupivacaine HCl for postsurgical analgesia in total knee arthroplasty. Knee 2012;19:530-6.
17. Gorfine SR, Onel E, Patou G, et al. Bupivacaine extended-release liposome injection for prolonged postsurgical analgesia in patients undergoing hemorrhoidectomy: a multicenter, randomized, double-blind, placebo-controlled trial. Dis Colon Rectum 2011;54:1552-9.
18. Smoot JD, Bergese SD, Onel E, et al. The efficacy and safety of DepoFoam bupivacaine in patients undergoing bilateral, cosmetic, submuscular augmentation mammoplasty: a randomized, double-blind, active-control study. Aesthet Surg J 2012;32:69-76.
19. International Conference on Harmonisation Working Group. ICH Harmonised Tripartite Guideline: Guideline for Good Clinical Practice E6 (R1). International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, 10 June 1996, Washington, DC, USA. Available at: http://www.ich.org/fileadmin/Public-Web-Site/ICH-Products/ Guidelines/Efficacy/E6-R1/Step4/E6-R1-Guideline.pdf [Last accessed: 19 April 2012]
20. World Medical Association. Declaration of Helsinki: ethical principles for medical research involving human subjects. Available at: http://www.wma.net/en/30publications/10policies/b3/17c.pdf [Last accessed 19 April 2012]
21. Bergese SD, Ramamoorthy S, Patou G, et al. Efficacy profile of liposome bupivacaine, a novel formulation of bupivacaine for postsurgical analgesia. J Pain Res 2012;5:107-16.
22. Langford RM, Chappell GM, Karrasch JA. A single administration of DepoBupivacaine intraoperatively results in prolonged detectable plasma bupivacaine and analgesia in patients undergoing inguinal hernia repair [abstract P-9088]. Presented at: Annual Postgraduate Assembly in Anesthesiology of the New York State Society of Anesthesiologists, 12-16 December 2008, New York, NY, USA.
23. White PF, Schooley GL, Ardeleanu M. Analgesia following a single administration of depobupivacaine intraoperatively in patients undergoing inguinal herniorrhaphy: preliminary dose-ranging studies [abstract S-242]. Anesth Analg 2009;108(Suppl 3S):S-242.
24. Miller H, Terem TM, Kheladze K, et al. A single administration of DepoBupivacaine intraoperatively provides three-day analgesia and reduction in use of rescue opioids in patients undergoing hemorrhoidectomy [abstract]. Presented at: Annual Meeting of the American Society of Colon and Rectal Surgeons, 2-6 May 2009, Hollywood, FL, USA.
25. Golf M, Daniels SE, Onel E. A phase 3, randomized, placebo-controlled trial of DepoFoam(R) bupivacaine (extended-release bupivacaine local analgesic) in bunionectomy. Adv Ther 2011;28:776-88.
26. Reisine T, Pasternak G. Opioid analgesics and antagonists. In: Hardman JG, Limbard LE, Molinoff PB, eds. Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th edn. New York, NY: McGraw-Hill, 1996:521-56
27. Hutchison RW, Chon EH, Tucker WF, et al. A comparison of a fentanyl, morphine, and hydromorphone patient-controlled intravenous delivery for acute postoperative analgesia: a multicenter study of opioid-induced adverse reactions. Hosp Pharm 2006;41:659-63.
28. Oderda GM, Evans RS, Lloyd J, et al. Cost of opioid-related adverse drug events in surgical patients. J Pain Symptom Manage 2003;25:276-83. (Pubitemid 36287086)
29. Pizzi LT, Toner R, Foley K, et al. Relationship between potential opioid-related adverse effects and hospital length of stay in patients receiving opioids after orthopedic surgery. Pharmacotherapy 2012;32:502-14.
30. Data on file. Parsippany, NJ, USA: Pacira Pharmaceuticals, Inc., 2011
31. Paice JA, Gordon DB, Contreras J, et al. Safe use of opioids in hosptials. Sentinel Event Alert 2012;49:1-5.
32. Hansen BP, Beck CL, Beck EP, et al. Postarthroscopic glenohumeral chondrolysis. Am J Sports Med 2007;35:1628-34. (Pubitemid 47476059)
33. Bailie DS, Ellenbecker TS. Severe chondrolysis after shoulder arthroscopy: a case series. J Shoulder Elbow Surg 2009;18:742-7.